CAS: 105613-48-7; Exametazime

该化合物是一种主要用于医学成像的放射性药剂化合物,特别是用于脑透析研究的单发射量计色成像(SPECT),它是六甲基丙烯胺氧化亚胺(HMPAO)的衍生物,其特点是能够跨越血液阻隔,允许脑血流视觉化.Exametazime通常被贴上技术-99m的标签,这是核医学中广泛使用的放射性同位素,为成像提供必要的伽马射线排放.该化合物以其稳定性和有利的药用皮肤素闻名,使其对诊断有效.在安全方面,该化合物一般都受到良好的保护,尽管与所有放射性制药学一样,它需要谨慎的处理和管理,以尽量减少辐射照射.它的使用在诊断各种...

结构式图片

合成工艺路线路线简述

    专利信息


    专利号:US-2012177593-A1
    优先权日:2009-07-20
    标 题 :Synthesis of dendrimer conjugates
    发明人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH
    权利人:BAKER JR JAMES R; ZHANG YUEHUA; THOMAS THOMMEY P; DESAI ANKUR MAHESH; UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis of therapeutic and diagnostic dendrimers. In particular, the present invention is directed to novel dendrimer conjugates, novel methods of synthesizing the same, compositions comprising the conjugates, as well as systems and methods utilizing the conjugates (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and/or targeting agents (e.g., in disease (e.g., cancer, inflammatory disease) diagnosis and/or therapy, pain therapy, etc.)). Accordingly, dendrimer conjugates of the present invention may further comprise at least two different components for targeting, imaging, sensing, and/or providing a therapeutic or diagnostic material and/or monitoring response to therapy. Furthermore, the novel synthesis methods of certain embodiments of the present invention provide significant advantages with regard to total reaction time and simplicity.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-9549995-B2
    优先权日:2012-03-26
    标 题:Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy
    发明人:YANG DAVID J; YU DONG-FANG
    权利人:UNIV TEXAS
    摘要:Novel methods of synthesis of ethylenedicysteine-sugar conjugates and therapeutic and diagnostic applications of such conjugates are disclosed. Methods of synthesizing these conjugates in high purity are also presented as using starting materials such as thiazolidine carboxylic acid. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these conjugates prepared herein, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-8147805-B2
    优先权日:2005-01-05
    标题:Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications
    发明人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND
    权利人:YANG DAVID; YU DONGFANG; CHANDA MITHU; AZHDARINIA ALI; OH CHANGSOK; KIM E EDMUND; UNIV T EXAS SYSTEM BOARD OF REGENTS
    摘要:Compositions and methods for dual imaging and for dual chemotherapy and radiotherapy are disclosed. More particularly, the invention concerns compounds comprising the structure X 1 —Y—X 2 , wherein Y comprises two or more carbohydrate residues covalently attached to one another, X 1 and X 2 are diagnostic or therapeutic moieties covalently attached to Y, provided that when Y does not comprise a glucosamine residue, X 1 and X 2 are diagnostic moieties. The present invention also concerns methods of synthesis of these compounds, application of such compounds for dual imaging and treatment of hyperproliferative disease, and kits for preparing a radiolabeled therapeutic or diagnostic compound.

    专利号:US-2015352230-A1
    优先权日:2013-01-11
    标 题:Synthesis and isolation of dendrimer based imaging systems
    发明人:MULLEN DOUGLAS GURNETT; BAKER JR JAMES R; BANASZAK HOLL MARK M; HUANG BAOHUA; DOUGHERTY CASEY; BALL JACK
    权利人:UNIV MICHIGAN
    摘要:The present invention relates to novel methods of synthesis and isolation of antibodies conjugated with modular dendrimer nanoparticles. In particular, the present invention is directed to antibodies conjugated with novel modular dendrimer nanoparticles having precise numbers of imaging agents, methods of synthesizing the same, compositions comprising such antibodies conjugated with such modular dendrimer nanoparticles, as well as systems and methods utilizing the conjugates (e.g., in imaging settings) (e.g., in diagnostic and/or therapeutic settings) (e.g., for the delivery of therapeutics, imaging, and/or targeting agents).

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Technetium Tc 99m Exametazime. 2023 Oct 15. 20(6):1124-40. doi: 10.1017/S1041610208007709. Epub 2008 Aug 27. 39(5):912-7. 19(6):567-72. doi: 10.1097/00006231-199806000-00009. 20(2):88-94. doi: 10.5603/NMR.2017.0014. 42(3):505-8. 11(11):791-9. doi: 10.1097/00006231-199011000-00008. 15(7):569-74. doi: 10.1097/00006231-199407000-00014. 33(7):487-95. doi: 10.1016/0006-3223(93)90002-u. 36(6):e35-6. doi: 10.1097/RLU.0b013e3182173954. 43(7):928-32. 5 Suppl
    1:S23-33. doi: 10.1111/jon19955s1s23. 21(9):913-23. doi: 10.1007/BF00238114. 23(3):247-55. doi: 10.1007/BF00837622. 32(4-5):679-85. doi: 10.1016/s0731-7085(03)00175-4. 49(8):1950-4. 28(8):1364-5. 19(10):981-7. doi: 10.1097/00006231-199810000-00008. 22(7):841. doi: 10.1097/00006231-200107000-00018. 41(5):934-40.

    合成参考文献


    参考文献:10.1007/s00259-002-0771-z
    摘要:Hesslewood SR. European system for reporting adverse reactions to and defects in radiopharmaceuticals: annual report 2000. European Journal of Nuclear Medicine and Molecular Imaging. 2002 Mar 22;29(5):bp13–9. doi: 10.1007/s00259-002-0771-z.
    参考文献:10.1007/s002590050488
    摘要:Blok D, Feitsma RIJ, Vermeij P, Pauwels EJK. Peptide radiopharmaceuticals in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging. 1999 Oct 27;26(11):1511–9. doi: 10.1007/s002590050488.
    参考文献:10.1016/j.nuclcard.2006.05.012
    摘要:Chang GY, Xie X, Wu JC. Overview of stem cells and imaging modalities for cardiovascular diseases. J Nucl Cardiol. 2006 Jul;13(4):554–69. doi: 10.1016/j.nuclcard.2006.05.012.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知